These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8020510)

  • 1. The chemistry of iomeprol and physico-chemical properties of its aqueous solutions and pharmaceutical formulations.
    Gallotti A; Uggeri F; Favilla A; Cabrini M; de Haën C
    Eur J Radiol; 1994 May; 18 Suppl 1():S1-12. PubMed ID: 8020510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability testing of iomeprol and iopamidol formulations subjected to X-ray radiation.
    Colombo Serra S; Fringuello Mingo A; Incardona C; Bergantin A; Vurro E; Bruno E; Tedoldi F
    Radiography (Lond); 2024 Jul; 30(4):1080-1084. PubMed ID: 38772064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical utility and safety profile of iomeprol.
    Rosati G
    Eur J Radiol; 1994 May; 18 Suppl 1():S120-4. PubMed ID: 8020514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind comparison of safety and efficacy of iomeprol and iopamidol in carotid digital subtraction angiography.
    Beltramello A; Piovan E; Rosta L
    Eur J Radiol; 1994 May; 18 Suppl 1():S67-72. PubMed ID: 8020521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iomeprol: a review of its use as a contrast medium.
    Dooley M; Jarvis B
    Drugs; 2000 May; 59(5):1169-86. PubMed ID: 10852647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Borate complexes of x-ray iodinated contrast agents: characterization and sorption studies for their removal from aqueous media.
    Rustighi I; Donati I; Ferluga M; Campa C; Pasqua AE; Rossi M; Paoletti S
    J Hazard Mater; 2012 Feb; 205-206():10-6. PubMed ID: 22245510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Stability of iodinated contrast media in UV-laser irradiation and toxicity of the photoproducts].
    Grönewäller EF; Wahl HG; Kehlbach R; Rodemann HP; Claussen CD; Duda SH
    Rofo; 1998 Nov; 169(5):537-41. PubMed ID: 9849607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of oxidation by-products of the iodinated X-ray contrast medium iomeprol during ozonation.
    Seitz W; Jiang JQ; Schulz W; Weber WH; Maier D; Maier M
    Chemosphere; 2008 Jan; 70(7):1238-46. PubMed ID: 17892892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic effects of ionic high-osmolar, nonionic monomeric, and nonionic iso-osmolar dimeric iodinated contrast media on renal tubular cells in vitro.
    Heinrich MC; Kuhlmann MK; Grgic A; Heckmann M; Kramann B; Uder M
    Radiology; 2005 Jun; 235(3):843-9. PubMed ID: 15845795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iomeprol: current and future profile of a radiocontrast agent.
    Katayama H; Spinazzi A; Fouillet X; Kirchin MA; Taroni P; Davies A
    Invest Radiol; 2001 Feb; 36(2):87-96. PubMed ID: 11224756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viscosity of iodinated contrast agents during renal excretion.
    Jost G; Lengsfeld P; Lenhard DC; Pietsch H; Hütter J; Sieber MA
    Eur J Radiol; 2011 Nov; 80(2):373-7. PubMed ID: 21376497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple regression analysis of octanol/water partition coefficients of non-ionic monomeric radiographic contrast media with the combination of three molecular descriptors.
    Violon D
    Br J Radiol; 1999 Jan; 72(853):44-7. PubMed ID: 10341688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irradiation in presence of iodinated contrast agent results in radiosensitization of endothelial cells: consequences for computed tomography therapy.
    Joubert A; Biston MC; Boudou C; Ravanat JL; Brochard T; Charvet AM; Estève F; Balosso J; Foray N
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1486-96. PubMed ID: 16029811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamic effects of iomeprol for injection in experimental animals.
    Cipolla P; Tirone P; Luzzani F; de Haën C
    Eur J Radiol; 1994 May; 18 Suppl 1():S32-42. PubMed ID: 8020517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of nonionic water-soluble contrast media: implications for their design.
    Sovak M; Ranganathan R
    Invest Radiol; 1980; 15(6 Suppl):S323-8. PubMed ID: 7203944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multistep approach for the structural identification of biotransformation products of iodinated X-ray contrast media by liquid chromatography/hybrid triple quadrupole linear ion trap mass spectrometry and (1)H and (13)C nuclear magnetic resonance.
    Kormos JL; Schulz M; Wagner M; Ternes TA
    Anal Chem; 2009 Nov; 81(22):9216-24. PubMed ID: 19842634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New non-ionic contrast: effects on the cardiovascular system.
    Pagny JY; Gaux JC
    Eur J Radiol; 1996 Nov; 23 Suppl 1():S2-5. PubMed ID: 9056156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biotransformation of selected iodinated X-ray contrast media and characterization of microbial transformation pathways.
    Kormos JL; Schulz M; Kohler HP; Ternes TA
    Environ Sci Technol; 2010 Jul; 44(13):4998-5007. PubMed ID: 20509647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicological safety assessment of iomeprol, a new X-ray contrast agent.
    Morisetti A; Tirone P; Luzzani F; de Haën C
    Eur J Radiol; 1994 May; 18 Suppl 1():S21-31. PubMed ID: 8020516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular rearrangement of 5-(a-hydroxy-alkanoylamino)-2,4,6-triiodo-isophthalic acid amides.
    Felder E; Gallotti A; Favilla A
    Invest Radiol; 1988 Sep; 23 Suppl 1():S101-5. PubMed ID: 3198328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.